Cigna is creating incentive to keep opioid doses low: Dr. Andrew Kolodny

Dr. Andrew Kolodny, co-director of opioid policy research at Brandeis University’s Heller School for Social Policy, and Dr. Salim Hayek, University Hospitals pain medicine professor, discuss Cigna offering a new opioid in place of OxyCotin.
Thu, Oct 5 20173:37 PM EST